Furthermore, PD-1+TIM-3-CD8+ T cells expressing BTLA are the largest tumor-specific CD8+ T cell subset among melanoma cases that show partial dysfunction with decreased IFN-γ production compared with BTLA- T cells (49). This evidence concerns the gene CD8A and melanoma.